Merck Sees FY23 Non-GAAP EPS $1.33-$1.38, Worldwide Sales $59.7B-$60.2B vs $55.98B Est.
Portfolio Pulse from Benzinga Newsdesk
Merck has projected its FY23 Non-GAAP EPS to be between $1.33 and $1.38, with worldwide sales expected to range from $59.7B to $60.2B, which is higher than the estimated $55.98B.
October 26, 2023 | 10:37 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merck's FY23 Non-GAAP EPS and sales projections exceed estimates, which could positively impact its stock price.
Merck's projected FY23 Non-GAAP EPS and worldwide sales are higher than the estimated figures. This positive financial outlook could increase investor confidence and drive up the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100